Emily Lynn Gable Robinson, M.A.ED., MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3632 W Market St Ste 103, Fairlawn, OH 44333 Phone: 330-670-8090 |
Gina Vitullo Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2820 W Market St Ste 110, Fairlawn, OH 44333 Phone: 330-835-4000 |
Alexis Enright, IMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 843 N Cleveland Massillon Rd Ste 6, Fairlawn, OH 44333 Phone: 330-723-7977 Fax: 330-725-5177 |
Ms. Elizabeth S. Helmuth Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3094 W Market St, Fairlawn, OH 44333 Phone: 330-571-0495 |
News Archive
Chaperone proteins play an important role in protein folding in human cells and in bacteria and are promising new targets for drugs to treat cancer and Alzheimer's disease and for novel antiviral drugs and antibiotics. How existing drugs such as Viagra or Cialis and a derivative of the drug Celebrex, for example, can reduce the activity of a specific chaperone protein, with the potential for anti-tumor and anti-Alzheimer's disease effects, is described in a Review article in DNA and Cell Biology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
The research objective of Dr.-Ing. Laura De Laporte, junior group leader at DWI - Leibniz Institute for Interactive Materials in Aachen, is to develop a minimally invasive therapy for spinal cord injury. Her goal and her scientific approach to develop an injectable material with the ability to provide biochemical and physical guidance for regenerating nerves across the injury site, was selected by the European Research Council.
First there was the "heart in a box," a revolutionary experimental technology that allows donor hearts to be delivered to transplant recipients warm and beating rather than frozen in an ice cooler. Now that same technology is being used to deliver "breathing lungs."
A new approach brings the hope of new therapeutic options for suppressing seasonal influenza and avian flu: On the basis of an empty - and therefore non-infectious - shell of a phage virus, researchers from Berlin have developed a chemically modified phage capsid that "stifles" influenza viruses.
A study by Nanyang Technological University (NTU)'s Assistant Professor Li Hoi Yeung, Assistant Professor Koh Cheng Gee and their team have made an important contribution to the understanding of the process that cells go through when they die. This process known as 'apoptosis' or programmed cell death, is a normal process in the human body which removes perhaps a million cells a second.
› Verified 4 days ago